We investigate the role of HLA-G in PBC by examining both genetic variability and the phenotypic expression of soluble HLA-G and their impact on a group of PBC patients and their therapy, comparing it to a control group and another autoimmune liver disease (AIH-1) from the same geographic area (Sardinia, Italy). Here, HLA-G is linked to primary biliary cholangitis.